Latest News VisionCare Ophthalmic Technologies Appoints Industry Veteran, Thierry Clidiere, to its Board of Directors By Staff Friday, March 11, 2016 12:15 AM SARATOGA, Calif.—VisionCare Ophthalmic Technologies, the developer, manufacturer and marketer of the Implantable Miniature Telescope the only FDA-approved surgical device for end-stage age-related macular degeneration (AMD), has appointed ophthalmic industry veteran, Thierry Clidiere, to its board of directors. Clidiere joins current board members, Wolfgang Tolle, VisionCare's president and CEO, and Life Science Alternative Funding representatives, Rich Gumer, Steve DeNelsky and David Kho."I'm excited to have Thierry join our board of directors," commented Wolfgang Tolle, VisionCare's president and CEO. "Thierry is a capable leader with a proven ability to grow markets in unique environments. His vast network of contacts worldwide, specifically in Europe, will be an asset to our team as we seek to expand our commercial efforts and bring our one-of-a-kind technology to AMD patients globally, especially in light of our recent achievement to obtain our first reimbursement outside the U.S., in parts of the U.K."Clidiere brings more than 40 years of executive experience in marketing, sales and acquisition management within the pharmaceutical and medical device industry. Launching his career at Pfizer, Inc., he held various roles in the areas of sales, marketing, operations and business development in several of their international offices. In 1983, he joined Alcon Laboratories, where he spent the next 28 years in executive management positions for Alcon Spain, Alcon Latin America, Alcon Europe, Alcon Middle East and Africa.